Endometrial cancer: staging and treatment in outline
- Disorder
Endometrial cancer usually bleeds early, after menopause, so most women are cured by an operation. Its stage and its type decide what else they need.
See it in 3D: Endometrium · Myometrium · Body of uterus · Cervix · Ovaries · Obturator nodes · External iliac nodes
What it is
Endometrial cancer arises in the lining of the uterus. Most cases are endometrioid adenocarcinomas driven by oestrogen that is not balanced by progesterone; a smaller group (serous, clear cell, carcinosarcoma) grows in a thin, atrophic lining, does not depend on oestrogen and spreads early. Diagnosis is by endometrial biopsy, in the office or guided by hysteroscopy. Staging follows FIGO and is surgical and pathological: how far the tumour has gone through the uterine wall, into the cervix, to the adnexa, nodes or beyond; the current FIGO system also weighs histological type and molecular class. Standard treatment is total hysterectomy with removal of both tubes and ovaries and assessment of the lymph nodes, followed by radiotherapy, chemotherapy or immunotherapy according to risk.
How to recognise it
- Abnormal bleeding is the presenting sign in the great majority, usually bleeding after menopause; any postmenopausal bleeding is investigated.
- Most risk factors share one root, oestrogen without progesterone: obesity (fat makes oestrogen), anovulation and PCOS, nulliparity, tamoxifen and oestrogen-only therapy with a uterus; diabetes and Lynch syndrome add risk.
- Combined hormonal contraception and the levonorgestrel intrauterine system protect the endometrium.
- Diagnosis needs tissue: office endometrial biopsy, or hysteroscopy with biopsy when sampling fails or bleeding persists.
- Pelvic MRI shows depth of myometrial invasion and cervical involvement and helps plan surgery; chest and abdominal imaging are added for high-grade types.
- Every tumour is tested for mismatch-repair proteins: it screens for Lynch syndrome and guides treatment. Molecular classes run from POLE-mutated (best outlook) through mismatch-repair deficient and no specific profile to p53-abnormal (worst).
Step by step
- Oestrogen without progesterone keeps the endometrium proliferating, with no progesterone signal to mature it and shed it.
- Months to years of proliferation → hyperplasia without atypia → atypical hyperplasia, which often already contains cancer.
- Atypical hyperplasia → low-grade endometrioid adenocarcinoma, which bleeds early and is usually found in stage I.
- A separate path: in an atrophic lining, a TP53 mutation → serous carcinoma, which spreads over the peritoneum early, much like ovarian cancer.
- Spread runs through the myometrium → cervix → serosa and adnexa → pelvic then para-aortic nodes → distant organs such as the lung.
The two families of endometrial cancer
| Feature | Endometrioid (oestrogen-driven) | Serous, clear cell, carcinosarcoma |
|---|---|---|
| Typical woman | Around menopause, obesity, PCOS, diabetes, few or no births | Older, often slim, years after menopause |
| Background lining | Hyperplasia | Atrophic endometrium or a polyp |
| Precursor | Atypical hyperplasia | Serous intraepithelial carcinoma |
| Typical molecular change | PTEN; often mismatch-repair deficient or POLE | TP53 (p53-abnormal) |
| Behaviour | Slow, usually confined to the uterus at diagnosis | Spreads early to the peritoneum and nodes, even with little invasion |
| Treatment beyond hysterectomy | Often none or vaginal brachytherapy in early stages | Full staging with omentum; chemotherapy usual, with or without radiotherapy |
Differential and risks
- Postmenopausal bleeding has a differential: atrophy (the commonest), polyps, hyperplasia, hormone therapy, cervical cancer and endometrial cancer. Only tissue separates them.
- Atypical hyperplasia is treated as near-cancer: hysterectomy, or a progestogen such as the levonorgestrel intrauterine system with repeated biopsies in a woman who wants to conceive.
- Fertility-sparing treatment with progestogens is only for low-grade endometrioid cancer confined to the endometrium on MRI, with close follow-up and hysterectomy after childbearing.
- Adjuvant treatment follows risk: low-risk stage I needs surgery alone; intermediate risk often gets vaginal brachytherapy; high-risk and advanced disease get pelvic radiotherapy and chemotherapy, with immunotherapy added for mismatch-repair deficient tumours.
- A mismatch-repair deficient tumour may mean Lynch syndrome: offer germline testing, because it predicts colorectal cancer in her and cancers in her relatives.
Next step / Initial management
- Bleeding after menopause, or persistent abnormal bleeding over 45 or with risk factors: transvaginal ultrasound and endometrial biopsy, and refer to gynaecology.
- Biopsy shows cancer or atypical hyperplasia: refer to gynaecological oncology, with pelvic MRI and chest imaging as the team requests.
- Surgery: total hysterectomy, removal of both tubes and ovaries and sentinel lymph node mapping, by laparoscopy where available; omentectomy for serous tumours.
- The pathology report, including mismatch-repair and p53 status, decides adjuvant treatment and whether to test for Lynch syndrome.
- Follow-up is clinical: teach her to report new bleeding, pain or cough; routine tumour markers are not needed in low-risk disease.
Common traps
- A thin endometrium on ultrasound settles persistent bleeding: ultrasound only lowers the probability, and serous cancers arise in thin atrophic linings, so bleeding that continues or returns still needs a biopsy.
- A normal Pap smear rules out endometrial cancer: cervical cytology samples the cervix and misses most endometrial cancers.
- A serous cancer confined to a polyp is low risk: serous tumours spread to the peritoneum with minimal invasion, so they need full staging and usually chemotherapy.
- Lynch syndrome only matters to the colon: in women endometrial cancer is often the first Lynch cancer, which is why every endometrial tumour is tested for mismatch repair.
Test yourself
Think of the answer, then tap the question to see it.
A 62-year-old with obesity and diabetes has one episode of postmenopausal bleeding. What is the next step and why?
Transvaginal ultrasound and an endometrial biopsy: bleeding is the early warning sign of endometrial cancer, and only tissue tells atrophy, polyp, hyperplasia and cancer apart.
Why is a serous endometrial carcinoma treated more aggressively than an endometrioid one of the same apparent size?
Serous tumours are TP53-driven and spread to the peritoneum and nodes early, even with little invasion of the wall, so they need full staging and usually chemotherapy.
Why is every endometrial cancer tested for mismatch-repair proteins?
A deficient result can reveal Lynch syndrome, with risks for her colon and for her relatives, and it changes treatment because these tumours respond to immunotherapy.
Which risk factor links obesity, anovulation and tamoxifen in endometrial cancer?
Oestrogen stimulation of the endometrium without enough progesterone: fat makes oestrogen, anovulation removes progesterone, and tamoxifen acts like oestrogen on the uterus.
Elsewhere in DurgiPedia
- Endometrial carcinoma: types and molecular groups
- Endometrioid endometrial carcinoma
- High-grade endometrial cancers: serous, clear cell, carcinosarcoma
- Endometrial polyps and hyperplasia
Connections
See it in 3D7
The structures of Durgical's 3D anatomy where it is found.
In Pharmacology3
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: Endometrial Cancer (StatPearls Publishing (NCBI Bookshelf), 2024); Endometrial Cancer Treatment (PDQ®), health professional version (National Cancer Institute (US), 2025); Lynch syndrome (MedlinePlus Genetics (U.S. National Library of Medicine), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
